Medscape is a formidable platform. Thirty years of content, 13 million members, 6,000+ disease articles, free CME, and — since November 2025 — a generative AI feature called Medscape AI. For a globally-minded clinician who wants broad clinical context and real-time medical news, it remains a strong default.
But for UK clinicians, the landscape has changed since 2024 in ways that matter.
Medscape AI launched as a global product with a US-leaning content library. The citations reference international literature rather than specifically UK guidance. The CME is primarily US-accredited and may not count toward UK revalidation. The platform is ad-supported, with pharmaceutical advertising alongside clinical content. And while it is available free to all members, it does not offer adaptive learning, Q-Banks, CPD integration, or clinical reasoning tools.
Here is what has changed — and what is now available specifically for UK practice.
For UK Guideline-Grounded Clinical Reference: iatroX
iatroX is the most direct Medscape alternative for UK clinicians. It is free, UKCA-marked, MHRA-registered, and architecturally grounded in NICE, CKS, SIGN, and BNF content. Every answer includes a citation linking to the primary UK guideline. It is designed for the UK clinician who needs a fast answer that reflects the sources their practice is audited against.
Beyond reference, iatroX offers a Knowledge Centre for structured guideline browsing, Brainstorm for clinical reasoning, an adaptive Q-Bank for learning and exam preparation, and a CPD module for professional development. None of these exist in Medscape.
The practical difference is architectural. When a UK GP asks about hypertension management, Medscape AI may reference ACC/AHA, ESC, or NICE — or a synthesis of all three. Ask iatroX gives you the NICE NG136 recommendation with a direct citation link. For a clinician whose practice is audited against NICE, that specificity matters.
For Deep Evidence Synthesis: OpenEvidence
OpenEvidence provides AI-powered evidence search grounded in peer-reviewed literature. It is free for verified healthcare professionals, cites primary research, and excels at questions that go beyond standard guideline recommendations — emerging treatments, evidence for off-label use, and literature-grounded clinical queries. Its 2026 expansion into Visits, Doctor Dialer, and Coding Intelligence has transformed it into a US-focused workflow platform, but the evidence search remains globally useful.
OpenEvidence is best when you need deep literature-based answers. It is not UK-guideline-specific.
For Authoritative UK Point-of-Care Summaries: NICE CKS
CKS remains the definitive UK primary care reference. Free, comprehensive, and linked directly to NICE guidance. Not AI-powered and not conversational, but it is the source of truth. Use alongside iatroX as the fast retrieval layer — iatroX gets you to the CKS-grounded answer in seconds rather than minutes of manual navigation.
For Prescribing: BNF
Non-negotiable for every prescribing decision. Free app. No AI tool replaces the BNF for drug dosages, interactions, contraindications, and monitoring requirements.
For Institution-Gated Depth: BMJ Best Practice
Available via OpenAthens for many NHS staff. BMJ Best Practice provides expert-written condition summaries with differential diagnosis tools, evidence appraisals, and international guideline coverage. Strong for hospital clinicians with institutional access who need depth beyond CKS.
For CME and CPD
Medscape's CME is primarily US-accredited. UK clinicians need CPD that counts toward revalidation and appraisal. The UK options: RCGP eLearning, NHS e-Learning for Healthcare, BMJ Learning, and — for AI-powered CPD — iatroX's CPD module, which turns clinical queries into documented professional development mapped to GMC domains.
The Practical Stack for UK Clinicians
Daily clinical questions: iatroX. Free, UK-specific, citation-first.
Detailed condition review: NICE CKS directly. Authoritative and comprehensive.
Prescribing: BNF app. Always.
Learning and CPD: iatroX Q-Bank and CPD module. Free.
Broader clinical context: Medscape AI for international perspective and clinical news. OpenEvidence for literature-grounded evidence.
This stack is almost entirely free. It is UK-specific where it needs to be and internationally informed where that adds value. And it replaces the Google habit that most clinicians still rely on.
What Changed Since 2024
In 2024, Medscape was the default because there was no UK-specific AI alternative that matched its conversational interface. In 2026, iatroX provides that interface — grounded in UK guidelines, with learning and CPD features that Medscape does not offer, and completely free. The switch is not about abandoning Medscape. It is about adding the UK-specific layer that Medscape was never designed to provide.